Reality of being an Advanced Cell Technology Long Shareholder

My intention for building www.InvestorStemCell.com was to ensure that the flow of ALL information remained open. The PGG was a small place and we quickly out grew it. www.InvestorStemCell.com is growing and that is why I am building www.StemCellCEO.com it is needed for CEO's of StemCell Companies to engage its investor base and deliver information whilst maintaining brand, SEC mandates and utterly important to shareholders

...

Originally Posted by rocky301

Mail,

The statement by Rabin that any significant revenues won't happen for "a couple of few years out"
and that most likely will be with Stargardt compassionate use, possibly in Europe is very much in line
with prior info I had posted in discussions with rumit and others. Below is an 8 month old post
using info available that puts the possible Stargardts Orphan program progress close to what Rabin is stating.
So no, not surprised at all.

...

As Americans anxiously await tonights speech from President Obama at 7pm EDT tonight on Jobs or should I say lack of jobs speech does the President realize this is truly his last chance? As one of the many independants that voted for and elected President Obama in 2008 I am not pleased with what I have seen for the most part. I understand he inherited a bad economy. I understand he inherited massive debt. I understand all this and I do not care any longer. I want results and I want people

...

Originally Posted by catchall

Since i live in the northeast and see the wrath of nature first hand it is clear what kind of world it would be if a michelle or paul or other none trusting in the eventual goodness of government had the pen of law.
Even in this little company the possibilities of science overcoming disease are daily confronted by the nonebelievers of mankind being the "healing hand of the prime mover".
There are physical elements that come from the explosions of stars (elemental factories). They have

...

Dear Members:
Changes at the CIRM this week may lead to expanding loans made to public companies. Jonathan Thomas, a founding partner of Saybrook Capital in Santa Monica, California, was elected by a 14-11 vote of the program's board. FCB-Pharmicell, a Korean pharmaceutical company, took a step closer to beginning commercial production of the world's first stem cell therapy as the Korea Food and Drug Administration said yesterday the approval will be given next week. Hearticellgram-AMI uses ...